Shengdong Ge

3PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 07, 2026
APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

|Apr 22, 2024
MED15 is upregulated by HIF-2α and promotes proliferation and metastasis in clear cell renal cell carcinoma via activation of SREBP-dependent fatty acid synthesis.

Xiaoliang Hua, Shengdong Ge, Li Zhang

|Sep 19, 2021
A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma.

Xiaoliang Hua, Shengdong Ge, Jiong Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Li Zhang

2 joint publications

Chaozhao Liang

1 joint publications

Xiaoliang Hua

1 joint publications

Cheng Yang